Literature DB >> 15542585

Rapid and large amount of autocrine IL-3 production is responsible for mast cell survival by IgE in the absence of antigen.

Masayuki Kohno1, Sho Yamasaki, Victor L J Tybulewicz, Takashi Saito.   

Abstract

Cross-linking FcepsilonRI on mast cells by immunoglobulin E (IgE) and antigen (Ag) initiates cascades leading to antiparasitic or allergic responses. It was recently reported that IgE without antigen, IgE(-Ag), actively promotes mast cell survival. Although we have demonstrated that the immunoreceptor tyrosine-based activation motif within FcRgamma is essential for IgE(-Ag)-induced mast cell survival, the underlying mechanism remains still unclear. Here, we investigated the mechanism of IgE(-Ag)-induced survival using mast cells lacking several downstream molecules. Lyn and Syk were essential, whereas Fyn, Gab2, and the phosphoinositide 3-kinase-Akt pathway were not critical for survival. Failure of survival in FcRgamma-/- bone marrow mast cells (BMMCs) was rescued by coculture with IgE-treated wild-type BMMCs, suggesting that survival is induced not directly through FcepsilonRI signals. We found that the survival is predominantly mediated by high production of interleukin 3 (IL-3), evidenced by severe impairment of survival by anti-IL-3 and in IL-3-/- BMMCs. The up-regulation of Bcl-xL/Bcl-2 by IgE was abrogated in IL-3-/- BMMCs, whereas the expression of histidine decarboxylase was normally induced. These results indicate that IL-3 plays a crucial role for IgE(-Ag)-induced mast cell survival, functioning in an autocrine manner by inducing the Bcl-xL/Bcl-2 via signal transducer and activator of transduction 5. We further suggest that IgE(-Ag)-mediated gene expression in mast cells is regulated at least 2 mechanisms: autocrine IL-3 dependent and independent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542585     DOI: 10.1182/blood-2004-07-2639

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

Review 1.  Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance.

Authors:  Toshiaki Kawakami; Jiro Kitaura
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

2.  Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade.

Authors:  Noria Harir; Cédric Boudot; Katrin Friedbichler; Karoline Sonneck; Rudin Kondo; Séverine Martin-Lannerée; Lukas Kenner; Marc Kerenyi; Saliha Yahiaoui; Valérie Gouilleux-Gruart; Jean Gondry; Laurence Bénit; Isabelle Dusanter-Fourt; Kaïss Lassoued; Peter Valent; Richard Moriggl; Fabrice Gouilleux
Journal:  Blood       Date:  2008-06-25       Impact factor: 22.113

Review 3.  Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases.

Authors:  Oliver T Burton; Hans C Oettgen
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

Review 4.  Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics.

Authors:  Britta Haenisch; Markus M Nöthen; Gerhard J Molderings
Journal:  Immunology       Date:  2012-11       Impact factor: 7.397

Review 5.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

6.  Allergen-independent immunomodulatory activities of immunoglobulin E.

Authors:  A A Horner; T Kawakami
Journal:  Clin Exp Allergy       Date:  2009-01-22       Impact factor: 5.018

7.  Thrombopoietin inhibits murine mast cell differentiation.

Authors:  Fabrizio Martelli; Barbara Ghinassi; Rodolfo Lorenzini; Alessandro M Vannucchi; Rosa Alba Rana; Mitsuo Nishikawa; Sandra Partamian; Giovanni Migliaccio; Anna Rita Migliaccio
Journal:  Stem Cells       Date:  2008-02-14       Impact factor: 6.277

8.  IgE-induced mast cell survival requires the prolonged generation of reactive oxygen species.

Authors:  Laura M Sly; Janet Kalesnikoff; Vivian Lam; Dana Wong; Christine Song; Stephanie Omeis; Karen Chan; Corinna W K Lee; Reuben P Siraganian; Juan Rivera; Gerald Krystal
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

9.  Pivotal advance: IgE accelerates in vitro development of mast cells and modifies their phenotype.

Authors:  Jun-ichi Kashiwakura; Wenbin Xiao; Jiro Kitaura; Yuko Kawakami; Mari Maeda-Yamamoto; Janet R Pfeiffer; Bridget S Wilson; Ulrich Blank; Toshiaki Kawakami
Journal:  J Leukoc Biol       Date:  2008-05-13       Impact factor: 4.962

10.  IgE influences the number and function of mature mast cells, but not progenitor recruitment in allergic pulmonary inflammation.

Authors:  Clinton B Mathias; Eva-Jasmin Freyschmidt; Benjamin Caplan; Tatiana Jones; Dimitri Poddighe; Wei Xing; Krista L Harrison; Michael F Gurish; Hans C Oettgen
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.